陆劲松-乳腺癌的内分泌治疗进展-last02-07-print.pptVIP

BIG1-98序贯分析:显示序贯治疗不优于弗隆单药治疗MouridsenH,etal.SABCS2008Abstract13.例数事件5年

DFS%来曲唑154624887.9LetTam154023687.6TamLet154825986.2随机分组后时间（年)DFS(%)6080100402000123456LetTamTamLet来曲唑1548LetTamTamLet来曲唑有风险的例数154614701371565154014671369546145713695612010-12-4复旦大学肿瘤医院乳腺癌研究所*BIG1-98序贯分析:乳腺癌相关事件*42%ofthepopulationisnodepositive;58%nodenegative.MouridsenHetal.Presentedat:SABCS2008,SanAntonio,Texas.GeneralSession1,#13.TAM?来曲唑vs.来曲唑总体151052000123456来曲唑TAM?来曲唑4.19.17.3